Trial Profile
Clinical Trials Insight: 700014704
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2006
Price :
$35
*
At a glance
- Drugs MLN 0415 (Primary)
- Indications Arthritis; Inflammation; Multiple sclerosis
- Focus Adverse reactions
- Sponsors Takeda Oncology
- 05 Sep 2006 New trial record.